Keryx Biopharmaceuticals (KERX)
A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.
Recs
VietSpeed
(< 20)
Submitted: 11/19/2009 3:16:46 AM :
Start Price:
$2.36
KERX Score:
+0.92
The future.
Recs
jackbot
(51.20)
Submitted: 11/18/2009 3:04:09 PM :
Start Price:
$2.25
KERX Score:
+2.87
This spry little biotech has a great balance sheet for such a small, experimental company.
Recs
Recs
waysane
(< 20)
Submitted: 11/10/2009 1:36:43 PM :
Start Price:
$2.14
KERX Score:
+10.77
Big Pharm always makes money
Recs
harlanror
(< 20)
Submitted: 11/9/2009 4:05:49 PM :
Start Price:
$2.29
KERX Score:
+3.69
this company has some strong drugs in the pipeline, should hit on many of them. stock could double or triple.
Recs
sOulbAitIsAFool
(< 20)
Submitted: 10/18/2009 7:47:09 PM :
Start Price:
$2.22
KERX Score:
+6.75
If you have a few extra coins, this is the one.
Recs
carsondyle
(32.84)
Submitted: 10/13/2009 11:30:12 AM :
Start Price:
$2.56
KERX Score:
-11.50
Speculative buy, also really like the potential I see in SNGX.
Recs
mmerinpa
(< 20)
Submitted: 9/27/2009 4:28:10 AM :
Start Price:
$2.62
KERX Score:
-13.66
it has two good drugs in phase 3 trials and just got approval in UK for one of them, a new class of drugs to treat multiple myeloma.
Recs
subzero701
(< 20)
Submitted: 9/25/2009 11:15:04 AM :
Start Price:
$2.77
KERX Score:
-18.58
Key developments have been announced to increase the likelyhood of new drugs being brought. The stock is selling at a major discount from its daily average moving price in past years.
Recs
Thelmal
(38.68)
Submitted: 9/25/2009 9:14:56 AM :
Start Price:
$2.45
KERX Score:
-7.43
On the BioTech radar - "merger worthy"
Recs
spadesnet
(< 20)
Submitted: 9/23/2009 11:39:52 PM :
Start Price:
$2.89
KERX Score:
-20.62
This Company is on its way up. They produce life saving and life improving treatments and are the real deal when it comes to bringing them to market. Having recently lost a family member to cancer, and knowing what it is like to wish one of these pharm companies would actually bring to market something that would help defeat this disease and improve the quality of life of a loved one I am deffinetly in their corner and feel very good about holding their stock. There recent study results on kidney disease and treatment add weight to my belief that they wil not only outperform the s&p they will simpley blow it away :)
Recs
tgarci2
(96.64)
Submitted: 9/23/2009 10:32:53 AM :
Start Price:
$2.90
KERX Score:
-20.45
I bought this stock at a pretty nice low back in May for $1.12, slightly speculative about its long trek through the path of a beaten down stock. I have done nothing but clap my hands frantically as news of it's big research drug got approval...I am very confident that KERX will go well into the double digit range by Q1 of next year, barring a health care meltdown
Recs
xlunarbase
(91.95)
Submitted: 9/21/2009 3:18:24 PM :
Start Price:
$2.12
KERX Score:
+8.79
All in at .14, it's in my watchlist at .19.
This baby has 2 phase 3s coming! Perifosine has the red carpet with orphan drug status!
Recs
jemsa
(83.96)
Submitted: 9/17/2009 9:34:30 AM :
Start Price:
$2.17
KERX Score:
+7.13
Folowing BravoBevo. Keryx pharmaceuticals soared 78% yesterday on news that KRX-0401 was approved for orphan drug status. This stock is sizzling hot and still has room to rise.
Recs
jhherrett
(23.67)
Submitted: 9/16/2009 11:25:21 PM :
Start Price:
$2.29
KERX Score:
+1.20
big news coming
Recs
StocksForCash
(< 20)
Submitted: 9/16/2009 10:50:14 AM :
Start Price:
$2.32
KERX Score:
-0.93
I know that this is probably not the best time to make this recommendation in the short term but it just now peeked its head above the $100M market cap threshold so I figured I would add for the long term while I had the chance.
Prospects look decent for its renal stuff and the chart looks great so I'm holding this for long term gains.
Recs
markwk
(35.38)
Submitted: 9/16/2009 10:36:42 AM :
Start Price:
$2.32
KERX Score:
-1.05
Will rebound to historical price levels then level off.
Recs
supez2004
(80.56)
Submitted: 3/3/2008 1:13:01 AM :
Start Price:
$5.75
KERX Score:
+44.37
Phase 3 for sulodexide unlikely to impress ...
Recs
DarthSamsa42
(35.64)
Submitted: 3/2/2008 9:51:06 PM :
Start Price:
$5.75
KERX Score:
-44.37
ARG:18.00, THM:21.69
Recs
slickchilli
(46.33)
Submitted: 2/23/2008 2:50:09 PM :
Start Price:
$5.39
KERX Score:
-40.09
Great for a remiss day-trader; it is almost a penny stock with reliable management in a beaten-down market whose price fluctuations are almost predictive by MACD.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 27 1 2 Next »